Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study

被引：0
|
作者：
Marina Amaral de Ávila Machado
Cristiano Soares de Moura
Steve Ferreira Guerra
Jeffrey R. Curtis
Michal Abrahamowicz
Sasha Bernatsky
机构：
[1] Research Institute of McGill University Health Centre,Division of Clinical Epidemiology
[2] University of Alabama at Birmingham,Division of Clinical Immunology and Rheumatology
[3] Research Institute of McGill University Health Centre,Department of Epidemiology, Biostatistics and Occupational Health
来源：
Arthritis Research & Therapy | / 20卷
关键词：
Rheumatoid arthritis; Tofacitinib; Disease-modifying antirheumatic drug; Biologic therapy; Comparative effectiveness research;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
    Clowse, Megan E. B.
    Feldman, Steven R.
    Isaacs, John D.
    Kimball, Alexandra B.
    Strand, Vibeke
    Warren, Richard B.
    Xibille, Daniel
    Chen, Yan
    Frazier, Donald
    Geier, Jamie
    Proulx, James
    Marren, Amy
    DRUG SAFETY, 2016, 39 (08) : 755 - 762
  • [32] DIRECT COMPARISON OF EFFECTIVENESS AND SAFETY OF TOFACITINIB AND BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-WORLD SETTINGS
    Iwamoto, N.
    Suzuki, T.
    Okada, A.
    Fujikawa, K.
    Aramaki, T.
    Mizokami, A.
    Ueki, Y.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 581 - 581
  • [33] EFFECTIVENESS, TOLERABILITY, AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA FROM THE ST. GALLEN AND AARAU COHORT
    Mueller, R.
    Popp, F.
    Mattowl, F.
    Durmisi, M.
    Souza, A.
    Schulze-Koops, H.
    Hasler, P.
    von Kempis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1409 - 1409
  • [34] THE EFFICACY AND SAFETY OF TOFACITINIB IN THE TREATMENT OF DMARDS NAIVE RHEUMATOID ARTHRITIS PATIENTS (EASTERN STUDY)
    Zhao, J.
    Wang, Y.
    Zhang, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1441 - 1441
  • [35] Time to Discontinuation of Tofacitinib in Rheumatoid Arthritis Patients with and Without Methotrexate: Results from a Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [36] Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia
    Deakin, Claire T.
    De Stavola, Bianca L.
    Littlejohn, Geoffrey
    Griffiths, Hedley
    Ciciriello, Sabina
    Youssef, Peter
    Mathers, David
    Bird, Paul
    Smith, Tegan
    O'Sullivan, Catherine
    Freeman, Tim
    Segelov, Dana
    Hoffman, David
    Seaman, Shaun R.
    JAMA NETWORK OPEN, 2023, 6 (06) : E2320851
  • [37] Tofacitinib for rheumatoid arthritis Reply
    Burmester, Gerd R.
    Benda, Birgitta
    Gruben, David
    Bradley, John
    Mebus, Charles
    LANCET, 2013, 381 (9880): : 1812 - 1813
  • [38] Tofacitinib: A Review in Rheumatoid Arthritis
    Sohita Dhillon
    Drugs, 2017, 77 : 1987 - 2001
  • [39] Tofacitinib for Treatment of Rheumatoid Arthritis
    Rakieh, Chadi
    Conaghan, Philip G.
    ADVANCES IN THERAPY, 2013, 30 (08) : 713 - 726
  • [40] Tofacitinib: A Review in Rheumatoid Arthritis
    Dhillon, Sohita
    DRUGS, 2017, 77 (18) : 1987 - 2001
12345